Thomas Civik

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jitendra Wadhane, Attorney-in-Fact for Thomas Civik
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas Civik

Form 4 holding CEO & Chairman of the Board, Director

Pyxis Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
2,503,050
Estimated value
$36,239
Report date
04 Sep 2026
Price
$0.9800
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Thomas Civik

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .